MedPath

Significant clinical efficacy of group interpersonal psychotherapy (IPT) as add-on treatment for depressive disorder: a randomized controlled trial.

Phase 3
Completed
Conditions
Depressive Symptoms (Scores on The Hamilton Depression Rating Scale&#44
HDRS)
group interpersonal psychotherapy&#44
group IPT&#44
major depressive disorder&#44
personality disorder&#44
melancholia
Registration Number
TCTR20201016003
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
64
Inclusion Criteria

Patients with an acute phase of major depressive disorder (MDD) as diagnosed using DSM-5 criteria, aged above 18 years, both sexes, and newly diagnosed within 3 months, with Thai HRSD ≥ 16 (moderate to severe depression) were included to the study.

Exclusion Criteria

Patients with the followings were excluded: (1) major depressive disorder with psychotic features; (2) schizophrenia and other psychotic disorders; (3) bipolar disorders; (4) dementias; (5) organic mental disorders; (6) substance-induced mood disorders, as assessed by psychiatric history taking and mental status examination by the investigators.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depressive Symptoms (Scores on The Hamilton Depression Rating Scale, HDRS) at the beginning (week 0), week 4, week 8, week 12, after the program (week 16) The Hamilton Depression Rating Scale (HDRS)
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath